Papillomavirus immune evasion strategies target the infected cell and the local immune system

C Zhou, ZK Tuong, IH Frazer - Frontiers in oncology, 2019 - frontiersin.org
Persistent infection with human papillomavirus (HPV) initiates~ 5% of all human cancers,
and particularly cervical and oropharyngeal cancers. HPV vaccines prevent HPV infection …

Recurrent respiratory papillomatosis: current and future perspectives

M Carifi, D Napolitano, M Morandi… - … and clinical risk …, 2015 - Taylor & Francis
Although recurrent respiratory papillomatosis is a benign disease of the upper aerodigestive
tract caused by infection with human papillomavirus, the disease process is unpredictable …

Current and future management of recurrent respiratory papillomatosis

R Ivancic, H Iqbal, B deSilva, Q Pan… - Laryngoscope …, 2018 - Wiley Online Library
Objectives Recurrent respiratory papillomatosis (RRP) is a chronic disease of the respiratory
tract that occurs in both children and adults. It is caused by the human papillomavirus (HPV) …

Recurrent respiratory papillomatosis

NN Venkatesan, HS Pine… - Otolaryngologic Clinics of …, 2012 - oto.theclinics.com
RRP is the term used to describe infection of the upper aerodigestive tract by human
papilloma virus (HPV). Although papillomas may present anywhere along the tract, the …

Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus‐6 and‐11

VR Bonagura, LJ Hatam, DW Rosenthal, JA De Voti… - Apmis, 2010 - Wiley Online Library
Bonagura VR, Hatam LJ, Rosenthal DW, DeVoti JA, Lam F, Steinberg BM, Abramson AL.
Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human …

Immune Suppression in Premalignant Respiratory Papillomas: Enriched Functional CD4+Foxp3+ Regulatory T Cells and PD-1/PD-L1/L2 Expression

LJ Hatam, JA DeVoti, DW Rosenthal, F Lam… - Clinical Cancer …, 2012 - AACR
Purpose: Respiratory papillomas, caused by human papillomaviruses types 6 and 11
(HPV6/11), are premalignant lesions with potential for malignant conversion. The cytokine …

[PDF][PDF] The immunological basis for immunization series: module 3: tetanus

World Health Organization - 2018 - apps.who.int
This module is part of the WHO series The immunological basis for immunization, which was
initially developed in 1993 as a set of eight modules, comprising one module on general …

Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre …

A Vambutas, J DeVoti, M Nouri, JW Drijfhout… - Vaccine, 2005 - Elsevier
This study was performed to test the therapeutic efficacy of overlapping long E6 and E7
peptides, containing both CD4+ T-helper and CD8+ CTL epitopes, on CRPV-induced …

Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis

R Ivancic, H Iqbal, B Desilva, Q Pan… - Clinical & Experimental …, 2020 - academic.oup.com
Recurrent respiratory papillomatosis (RRP) is characterized by benign exophytic lesions of
the respiratory tract caused by the human papillomavirus (HPV), in particular low-risk HPV6 …

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis

VR Bonagura, Z Du, E Ashouri, L Luo, LJ Hatam… - Human immunology, 2010 - Elsevier
The polymorphic killer cell immunoglobulin-like receptors (KIR) control natural killer (NK)
cell response against viral infection and tumor transformation. Here we investigated if select …